143 related articles for article (PubMed ID: 32328475)
1. A Polyamine-Based Dinitro-Naphthalimide Conjugate as Substrates for Polyamine Transporters Preferentially Accumulates in Cancer Cells and Minimizes Side Effects
Ma J; Li Y; Li L; Yue K; Liu H; Wang J; Xi Z; Shi M; Zhao S; Ma Q; Liu S; Guo S; Liu J; Hou L; Wang C; Wang PG; Tian Z; Xie S
Front Chem; 2020; 8():166. PubMed ID: 32328475
[TBL] [Abstract][Full Text] [Related]
2. A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent.
Ma J; Li L; Yue K; Zhang Z; Su S; Chen Y; Yu L; Zhang P; Ma R; Li Y; Ma Y; Jia H; Wang C; Wang J; Xie S
Eur J Med Chem; 2021 Oct; 221():113469. PubMed ID: 33965862
[TBL] [Abstract][Full Text] [Related]
3. Polyamine-Based Pt(IV) Prodrugs as Substrates for Polyamine Transporters Preferentially Accumulate in Cancer Metastases as DNA and Polyamine Metabolism Dual-Targeted Antimetastatic Agents.
Liu H; Ma J; Li Y; Yue K; Li L; Xi Z; Zhang X; Liu J; Feng K; Ma Q; Liu S; Guo S; Wang PG; Wang C; Xie S
J Med Chem; 2019 Dec; 62(24):11324-11334. PubMed ID: 31765154
[TBL] [Abstract][Full Text] [Related]
4. A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance.
Li Y; Yue K; Li L; Niu J; Liu H; Ma J; Xie S
Bioorg Chem; 2020 Aug; 101():104011. PubMed ID: 32599363
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of novel amonafide-polyamine conjugates as anticancer agents.
Wang Y; Zhang J; Li M; Li M; Xie S; Wang C
Chem Biol Drug Des; 2017 May; 89(5):670-680. PubMed ID: 27762101
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of naphthalimide-polyamine conjugates modified by alkylation as anticancer agents through p53 pathway.
Dai F; He H; Xu X; Chen S; Wang C; Feng C; Tian Z; Dong H; Xie S
Bioorg Chem; 2018 Apr; 77():16-24. PubMed ID: 29316508
[TBL] [Abstract][Full Text] [Related]
7. 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway.
Xie SQ; Zhang YH; Li Q; Xu FH; Miao JW; Zhao J; Wang CJ
Apoptosis; 2012 Jul; 17(7):725-34. PubMed ID: 22395446
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Biological Evaluation of Mitochondria-Targeted Flavone-Naphthalimide-Polyamine Conjugates with Antimetastatic Activity.
Dai F; Li Q; Wang Y; Ge C; Feng C; Xie S; He H; Xu X; Wang C
J Med Chem; 2017 Mar; 60(5):2071-2083. PubMed ID: 28177238
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and in vitro cytotoxicity of naphthalimide polyamine conjugates as antitumor agents].
Mei ZH; Tian ZY; Ma HX; Xie SQ; Zhao J; Wang CJ
Yao Xue Xue Bao; 2009 Jul; 44(7):754-7. PubMed ID: 19806915
[TBL] [Abstract][Full Text] [Related]
10. Recent developments on 1,8-Naphthalimide moiety as potential target for anticancer agents.
Tandon R; Luxami V; Tandon N; Paul K
Bioorg Chem; 2022 Apr; 121():105677. PubMed ID: 35202852
[TBL] [Abstract][Full Text] [Related]
11. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
Wu A; Mei P; Xu Y; Qian X
Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Evaluation of Novel Aromatic Imide-Polyamine Conjugates.
Li M; Wang Y; Zhang J; Xie S; Wang C; Wu Y
Molecules; 2016 Nov; 21(12):. PubMed ID: 27916902
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects and preliminary systemic toxicity of ANISpm in vivo and in vitro.
Li M; Li Q; Zhang YH; Tian ZY; Ma HX; Zhao J; Xie SQ; Wang CJ
Anticancer Drugs; 2013 Jan; 24(1):32-42. PubMed ID: 23032518
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic and molecular modeling methods to study the interaction between naphthalimide-polyamine conjugates and DNA.
Tian Z; Huang Y; Zhang Y; Song L; Qiao Y; Xu X; Wang C
J Photochem Photobiol B; 2016 May; 158():1-15. PubMed ID: 26926663
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents.
Tian ZY; Xie SQ; Du YW; Ma YF; Zhao J; Gao WY; Wang CJ
Eur J Med Chem; 2009 Jan; 44(1):393-9. PubMed ID: 18423800
[TBL] [Abstract][Full Text] [Related]
16. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
Aziz SM; Gillespie MN; Crooks PA; Tofiq SF; Tsuboi CP; Olson JW; Gosland MP
J Pharmacol Exp Ther; 1996 Jul; 278(1):185-92. PubMed ID: 8764350
[TBL] [Abstract][Full Text] [Related]
17. 5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.
Xie L; Cui J; Qian X; Xu Y; Liu J; Xu R
Bioorg Med Chem; 2011 Jan; 19(2):961-7. PubMed ID: 21208805
[TBL] [Abstract][Full Text] [Related]
18. Study on the interaction of polyamine transport (PAT) and 4-Chloro-naphthalimide-homospermidine conjugate (4-ClNAHSPD) by molecular docking and dynamics.
Tian Z; Tian L; Zhao S; Shi M; Guo S; Wang C; Tian Z; He X
J Biomol Struct Dyn; 2022 Jan; 40(1):290-296. PubMed ID: 32856528
[TBL] [Abstract][Full Text] [Related]
19. A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis.
Chen Z; Liang X; Zhang H; Xie H; Liu J; Xu Y; Zhu W; Wang Y; Wang X; Tan S; Kuang D; Qian X
J Med Chem; 2010 Mar; 53(6):2589-600. PubMed ID: 20170164
[TBL] [Abstract][Full Text] [Related]
20. Overview of naphthalimide analogs as anticancer agents.
Lv M; Xu H
Curr Med Chem; 2009; 16(36):4797-813. PubMed ID: 19929786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
